Abstract:Key PointsResveratrol, a small polyphenol, has been discovered and re-discovered as a potential therapeutic in recent years. Although putative cardioprotective effects were first noted in 1982, it was only after a 1992 report of high levels of resveratrol in red wine that these effects were investigated extensively. In 1997, resveratrol was isolated in a screen for cyclooxygenase inhibitors, and was shown to be an effective chemotherapeutic and chemopreventive agent. Moreover, in 2003, it was identified as the top hit in a screen for activators of sirtuin deacetylases and was shown to extend the lifespans of lower organisms.The number of reported effects for resveratrol is constantly growing. Many direct targets have been identified in vitro, and protective effects have been demonstrated in various rodent models of disease.Pharmacokinetic studies have consistently shown that levels of resveratrol in serum do not reach the concentrations required for most of the reported in vitro effects, or do so only transiently. In vivo evidence has therefore become increasingly important in efforts to understand how resveratrol elicits its effects in mammals.One possibility that has been suggested based on data from lower organisms is that resveratrol acts as a caloric restriction mimetic. This hypothesis is intriguing because caloric restriction seems to slow the intrinsic rate of ageing, and improve general health, rather than block specific disease processes.The many reported in vivo effects of resveratrol are reviewed here and, whenever possible, have been related to putative mechanisms and targets. Determining the mechanism(s) by which resveratrol and similar molecules act, and developing methods to improve bioavailability and/or specificity, has enormous potential to benefit human health.

Resveratrol targeting the Wnt signaling pathway: A focus on therapeutic activities

Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway

Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers

Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways

Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects

Resveratrol-Induced Signal Transduction in Wound Healing

Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways

Resveratrol: an Overview of Its Anti-Cancer Mechanisms

Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications

Molecular Basis of the Beneficial Actions of Resveratrol

Multidimensional biological activities of resveratrol and its prospects and challenges in the health field

Resveratrol: A Double-Edged Sword in Health Benefits

Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review

Structure Modification of Resveratrol and Pharmacological Activity

Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease.

Resveratrol: Multi-Targets Mechanism on Neurodegenerative Diseases Based on Network Pharmacology

Therapeutic potential of resveratrol: the in vivo evidence

Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics

Resveratrol Promotes Diabetic Wound Healing by Inhibiting Notch Pathway

Resveratrol and its analogues: promising antitumor agents.

Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action